7. Ell<strong>is</strong> PM, <strong>Shepherd</strong> FA. Chemotherapy for Recurrent or Refractory advanced Non-Small Cell Lung Cancer. Principles and Practice of Lung Cancer The Official Reference Text of the IASLC, 4 th Edition. Lippincott Williams & Wilkins. 2010. 669-683. 8. Huang CH, <strong>Shepherd</strong> FA, Kelly K. Chemotherapy for Small cell Lung Cancer. Principles and Practice of Lung Cancer, the Official Reference Text of the IASLC, 4 th Edition. Lippincott Williams & Wilkins. 2010. 847-866 16
13. ABSTRACTS AND PAPERS PRESENTED AT SCIENTIFIC MEETINGS LAST 5 YEARS OUT OF A TOTAL OF 444: 1. Franks KN, Bezjak A, Pearson S, Cho BC, Payne D, Sun A, Waddell TK, <strong>Shepherd</strong> FA, Keshavjee S. Stereotactic body radiotherapy (SBRT) and medical inoperability of early stage non-small cell lung cancer. J Clin Oncol 24, 18S: 672s (Abstract #17074), 2006. 2. <strong>Shepherd</strong> FA. Adjuvant Chemotherapy for Non-Small Cell Lung Cancer. Presented at the 18 th International Congress on Anti Cancer Treatment. Par<strong>is</strong> Feb 2007. 3. Douillard JY, Tribodet H, Rosell R, DeLena M, <strong>Shepherd</strong> FA. Adjuvant chemotherapy with c<strong>is</strong>platin-vinorelbine in totally resected non-small cell lung cancer: results of the ANITA trial and confirmatory data from the Lung Adjuvant C<strong>is</strong>platin Evaluation (LACE). Presented at the 18 th International Congress on Anti Cancer Treatment. Par<strong>is</strong> Feb 2007. 4. Bradbury PA, Marshall AL, Kulke MH, <strong>Shepherd</strong> FA. Prognostic significance of nuclear exc<strong>is</strong>ion (NER) and base exc<strong>is</strong>ion (BER) DNA repair gene polymorph<strong>is</strong>ms in esophageal cancer. J Clin Oncol 25, 18S: 99s, 2007. Journal of Clin Onc 25, 18S. Presented at ASCO 2007. 5. Arnold AM, Smylie M, Ding K, <strong>Shepherd</strong> FA. Randomized phase II study of maintenance vandetanib (ZD6474) in small cell lung cancer (SCLC) patients who have a complete or partial response to induction therapy: NCIC CTG BR.20. Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 6. Butts CA, Bodkin D, Middleman AL, <strong>Shepherd</strong> FA. Gemcitabine/platinum alone or in combination with cetuximab as first-libne treatment for advanced non-small celllung cancer (NSCLC). Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 7. Fruh M, Tribodet H, Pignon J, <strong>Shepherd</strong> FA. A pooled analys<strong>is</strong> of the effect of age on adjuvant c<strong>is</strong>platin-based chemotherapy for completely resected non-small cell lung cancer (NSCLC). Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 8. <strong>Shepherd</strong> FA, Ding K, Sakurada A, Da Cuhna Santos G, Updated molecular analyses of exons 19 and 21 of the epidermal growth factor receptor (EGFR) gene and codons 12 and 13 of the KRAS gene in non-small celllung cancer (NSCLC) patients treated with erlotinib in National Cancer Institute of Canada. Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 9. Tsao MS, Aviel-Ronen S, Ding K, <strong>Shepherd</strong> FA. P53 protein over-expression but not p53 gene mutation <strong>is</strong> a poor prognostic marker and a predictive marker for survival benefit from adjuvant chemotherapy in non-small cell lung cancer (NSCLC) in the JBR.10 Trial. Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 10. Bezjak A, Lee CW, Ding K, Winton T, <strong>Shepherd</strong> FA. Quality of life (QOL) impact of adjuvant chemotherapy for early stage non-small cell lung cancer (NSCLC): final analys<strong>is</strong> of JBR.10 randomized trial. Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. 11. Papadimitrakopoulou V, Soria JC, Douillard JY, Giaccone G, <strong>Shepherd</strong> FA. A phase II study of RAD001 (R) (everolimus) monotherapy in patients (pts) with advanced nonsmall cell lung cancer (NSCLC) failing prior platinum-based chemotherapy (C) or prior C and EGFR inhibitors (EGFR-I). Journal of Clin Onc 25, 18S. Presented at ASCO June 2007. Journal of Thor Onc 2, 8. Presented at the 12 th World Conference on Lung Cancer, Seoul, Korea, Sept 2007. 17
- Page 1 and 2: CURRICULUM VITAE FRANCES ALICE SHEP
- Page 3 and 4: 2012 Royal College of Physicians an
- Page 5 and 6: docetaxel +/- Velcade in advanced N
- Page 7 and 8: trial of adjuvant vinorelbine plus
- Page 9 and 10: 45. Sculier JP, Chansky K, Crowley
- Page 11 and 12: 72. Patel A, Anraku M, Darling GE,
- Page 13 and 14: 100. Jang RW, Isogai PK, Mittmann N
- Page 15: 131. Horgan AM, Yang B, Azad AK, Am
- Page 19 and 20: 23. Jang RW, LeMaitre A, Ding K, Wi
- Page 21 and 22: Association of Radiation Oncology (
- Page 23 and 24: the elderly: A population-based out
Change language